Research Article
Nebivolol Attenuates Neutrophil Lymphocyte Ratio: A Marker of Subclinical Inflammation in Hypertensive Patients
Table 2
Comparison of the lipid profile and blood sugar between two groups.
| Parameters | Nebivolol group | Metoprolol group | |
| Total cholesterol (mg/dl) | | | | Before | 187.32 ± 31.22 | 188.82 ± 33.43 | 0.88 | After | 184.65 ± 27.35 | 190.68 ± 36.92 | 0.62 | | 0.54 | 0.16 | | Triglycerides (mg/dl) | | | | Before | 130.36 ± 60.54 | 133.34 ± 43.86 | 0.73 | After | 126.45 ± 54.62 | 138 ± 52.45 | 0.62 | | 0.13 | 0.17 | | LDL-cholesterol (mg/dl) | | | | Before | 127.42 ± 44.43 | 134.54 ± 42.56 | 0.79 | After | 123.65 ± 38.85 | 136.82 ± 36.78 | 0.80 | | 0.54 | 0.82 | | HDL-cholesterol (mg/dl) | | | | Before | 43.85 ± 12.46 | 44.42 ± 8.62 | 0.64 | After | 45.32 ± 11.52 | 43.67 ± 11.82 | 0.49 | | 0.13 | 0.17 | | Blood sugar (mg/dl) | | | | Before | 84.82 ± 8.82 | 86.42 ± 11.2 | 0.54 | After | 82.54 ± 9.89 | 87.56 ± 10.5 | 0.68 | | 0.34 | 0.56 | |
|
|
LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol; values are mean ± SD; paired t-test; independent sample t-test.
|